Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Queensland Health
Moodys
QuintilesIMS
Covington

Generated: June 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011839

« Back to Dashboard

NDA 011839 describes PROVERA, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from six suppliers. Additional details are available on the PROVERA profile page.

The generic ingredient in PROVERA is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 011839
Tradename:PROVERA
Applicant:Pharmacia And Upjohn
Ingredient:medroxyprogesterone acetate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 011839
Suppliers and Packaging for NDA: 011839
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROVERA medroxyprogesterone acetate TABLET;ORAL 011839 NDA Pharmacia and Upjohn Company LLC 0009-0050 0009-0050-02 1 BOTTLE in 1 CARTON (0009-0050-02) > 100 TABLET in 1 BOTTLE
PROVERA medroxyprogesterone acetate TABLET;ORAL 011839 NDA Pharmacia and Upjohn Company LLC 0009-0050 0009-0050-11 500 TABLET in 1 BOTTLE (0009-0050-11)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
Healthtrust
Colorcon
Queensland Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.